Mitogen-activated protein kinase 2 regulates physiological and pathological bone turnover
Open Access
- 20 November 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 28 (4) , 936-947
Abstract
The objective of this study was to investigate the role of the serine‐threonine kinase mitogen‐activated protein kinase 2 (MK2) in bone homeostasis. Primary bone cell cultures from MK2+/+ and MK2–/– mice were assessed for osteoclast and osteoblast differentiation, bone resorption, and gene expression. Bone architecture of MK2+/+ and MK2–/– mice was investigated by micro–computed tomography and histomorphometry. Ovariectomy was performed in MK2+/+ and MK2–/– mice to assess the role of MK2 in postmenopausal bone loss. Osteoclastogenesis, bone resorption, and osteoclast gene expression were significantly impaired in monocytes from MK2–/– compared to MK2+/+ mice. Mechanistically, loss of MK2 causes impaired DNA binding of c‐fos and nuclear factor of activated T cells cytoplasmic 1 (NFATc1) to tartrate‐resistant acid phosphatase (TRAP) and the calcitonin receptor gene promoter. In addition, MK2–/– mice showed an age‐dependent increase in trabecular bone mass and cortical thickness, fewer osteoclasts, and lower markers of bone resorption than MK2+/+ mice. Furthermore, MK2–/– mice were protected from ovariectomy‐induced bone loss. Osteoblastogenesis and bone formation were unchanged in MK2–/– mice, whereas osteoblast expression of osteoprotegerin (OPG) and serum levels of OPG were higher in MK2–/– than in MK2+/+ mice. Loss of MK2 effectively blocks bone resorption and prevents the development of postmenopausal bone loss. Small‐molecule inhibitors of MK2 could thus emerge as highly effective tools to block bone resorption and to treat postmenopausal bone loss. © 2013 American Society for Bone and Mineral Research.Keywords
This publication has 35 references indexed in Scilit:
- Erk1 Positively Regulates Osteoclast Differentiation and Bone Resorptive ActivityPLOS ONE, 2011
- Increased bone density and resistance to ovariectomy‐induced bone loss in FoxP3‐transgenic mice based on impaired osteoclast differentiationArthritis & Rheumatism, 2010
- The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in miceJournal of Clinical Investigation, 2010
- Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitisBone, 2009
- JNK Activity Is Essential for Atf4 Expression and Late-Stage Osteoblast DifferentiationJournal of Bone and Mineral Research, 2009
- MK2 controls the level of negative feedback in the NF-κB pathway and is essential for vascular permeability and airway inflammationJournal of Experimental Medicine, 2007
- Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systemsNature Reviews Immunology, 2007
- The Mitogen-Activated Protein Kinase (MAPK)-Activated Protein Kinases MK2 and MK3 Cooperate in Stimulation of Tumor Necrosis Factor Biosynthesis and Stabilization of p38 MAPKMolecular and Cellular Biology, 2007
- Differential tissue expression and activation of p38 MAPK α, β, γ, and δ isoforms in rheumatoid arthritisArthritis & Rheumatism, 2006
- Tissue-specific and Ubiquitous Promoters Direct the Expression of Alternatively Spliced Transcripts from the Calcitonin Receptor GeneJournal of Biological Chemistry, 2001